0.0100
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Peiwen Yu | President, CEO & Director | -- | -- | 1970 |
| Dr. Steven Josephs | Chief Science Officer and Member of Advisory Board | -- | -- | -- |
| Dr. Feng Lin | Director of Research and Member of Advisory Board | -- | -- | -- |
Entest Group, Inc.
No. 911 Bao’an Book City
Xinqiao Street Central Road Bao’an District
Shenzhen
China
- Sector:
- Financial Services
- Industry: Shell Companies
Description
Entest Group, Inc. does not have significant operations. It intends to seek business opportunities to review and analyze for purposes of effecting a merger, acquisition, or other business combination with an operating company business. The company was formerly known as Entest Biomedical, Inc. and changed its name to Entest Group, Inc. in February 2018. Entest Group, Inc. was founded in 2008 and is based in Shenzhen, China.
Corporate Governance
Entest Group, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available